| Literature DB >> 35818160 |
Fettah Eren1, Recep Aygul1, Sevde Tenekeci1, Serefnur Ozturk1.
Abstract
Multifocal motor neuropathy (MMN) is an immune-mediated and acquired demyelinating motor polyneuropathy. Several cases of polyneuropathy associated with severe acquired respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination have been reported. However, MMN has not been reported as a complication of SARS-CoV-2 vaccination. In this study, we report a case of MMN with progressive muscle weakness following the second dose of the Pfizer-BioNTech mRNA vaccine. It was diagnosed by clinical evaluation and electroneuromyography. SARS-CoV-2 vaccination is increasing rapidly all over the world. Some cases of polyneuropathy, especially Guillain-Barré syndrome, have been reported after vaccination. This is the first case report of MMN after SARS-CoV-2 vaccination.Entities:
Keywords: Motor neuropathy; SARS-CoV-2; coronavirus disease 2019; muscle weakness; polyneuropathy; vaccination
Mesh:
Substances:
Year: 2022 PMID: 35818160 PMCID: PMC9280831 DOI: 10.1177/03000605221110709
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.573